Stocks
Polyrizon Ltd.PLRZ
NASDAQHealthcareBiotechnology$8.70
Price as of · delayed, not real-time
A specialty pharmaceutical developer focused on advanced drug delivery systems, Polyrizon Ltd. is advancing a pipeline of products using its proprietary hydrogel-based platform. The company is in clinical-stage development, with investors tracking its progress toward regulatory approval and commercialization.
52W Range: $2.88-$18.20
Congressional Interest in Polyrizon Ltd. (PLRZ)
No congressional trades have been disclosed for Polyrizon Ltd. (PLRZ) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PLRZ?
No congressional trades found for this stock.